In sports medicine and orthopedic reconstruction, interference screws, despite being commonly seen implant devices, perform vital functions of mechanical load transmission and biological fixation. These implants mechanically secure grafts (tendons, ligaments etc.) within bone tunnels and substantially determine graft healing outcomes as well as long-term joint stability.
Distinct from conventional orthopedic bone screws, interference screws operate at the junction between hard bone tissue and soft tendinous/ligamentous tissue. Such unique anatomical placement dictates that registration review must cover static pull-out fixation strength, dynamic osseointegration performance and stress shielding effects comprehensively.
Consistent with evolving regulatory review trends, CMDE (Center for Medical Device Evaluation, NMPA) has shifted its assessment paradigm for sports medicine implants from isolated physical property testing toward full-lifecycle risk management. For teams preparing interference screw registration, basic verification of screw insertion feasibility and tensile strength alone is insufficient to pass technical review. Comprehensive evidence covering material characterization, biomechanical matching and long-term osseointegration validation is mandatory to meet stringent review criteria.
Registration challenges for interference screw products seldom arise from late-stage dossier compilation but rely on accurate product feature definition at project initiation, which directly determines subsequent registration submission routes.
Reviewers prioritize material characteristic evaluation upon initial product assessment. Current interference screws fall into three major categories: metallic materials (titanium alloy, stainless steel), absorbable polymers such as PLA, and composite materials.
Metallic screws are generally regulated as Class II devices, with review focus on long-term corrosion fatigue and metallic ion release.
Absorbable screws are mostly categorized as Class III devices. Core review concerns cover aseptic inflammation triggered by degradation byproducts and synchronization between degradation rate and bone healing cycle. Excessively fast degradation causes fixation failure, while overly slow degradation results in stress shielding and impedes bone tunnel remodeling.
Classification shall not be determined empirically; R&D teams shall clarify raw material synthesis route (e.g., PLLA manufacturing process), molecular weight distribution and residual monomer control in early phase, which lay the foundation for subsequent biological evaluation.
Thread configuration, self-tapping feature and head design of interference screws shall match dedicated surgical instruments and standard clinical procedures. Discovery of insufficient torque resistance or high bone tunnel splitting risk induced by improper thread design at registration testing stage would force full project redesign.
For interference screws, reviewers focus beyond static mechanical indicators and attach greater importance to dynamic product performance under complicated physiological conditions.
Degradation kinetics: Detailed in vitro degradation test data shall be submitted to elaborate molecular weight decline curve, mass loss profile and mechanical property deterioration curve under simulated body fluid environment.
Metabolic safety: Metabolic pathways of degradation metabolites such as lactic acid shall be clarified. It is a core review threshold to confirm whether local accumulation of degradation byproducts triggers granuloma, aseptic inflammation or rejection response. Toxicology and immunogenicity verification of degraded substances are required; product safety cannot be concluded merely based on medical-grade raw material qualification.
Review focus: Whether the product maintains sufficient primary fixation while its modulus gradually decreases synchronously with bone healing to realize optimized flexible-rigid mechanical matching.
Verification requirements: Static tensile test alone cannot validate clinical effectiveness. Fatigue testing under simulated physiological environment and cyclic loading test mimicking in-vivo bone tunnel conditions are mandatory to verify long-term stability under continuous dynamic load.
Professional verification criteria: Verification dataset of interference screws shall include in-vivo animal studies or high-precision biomechanical simulation tests to characterize graft healing inside bone tunnel, bone ingrowth efficiency and osseointegration status at screw-bone interface. Core evaluation criterion shifts from mechanical hardness to the capacity facilitating biological fusion between graft and host bone.
The selection of clinical evaluation pathways for interference screws is the most disputable part during project implementation.
Important Note: Comparison shall not be limited to macroscopic performance. Microscopic indicators including thread geometric parameters, surface roughness and material crystallinity must be covered. Any design modification such as optimized thread angle shall be supported by biomechanical test data to prove no compromise to product safety or efficacy.
Important Note: Clinical trial design focuses on osseointegration rather than mere fixation stability. Primary endpoints cover bone tunnel remodeling, graft laxity and patients’ joint function scoring.
The following issues occur frequently in the review and supplementary notification of interference screws. These issues involve various details of verification design and should be considered and prepared in advance as early as possible.
| Common Risk Points Likely to Trigger Supplementary Data Requests |
|---|
For the registration submission of absorbable material interference screws, only in vitro degradation data (such as strength retention rate after XX weeks) is provided, but the corresponding relationship between the data and the clinical bone tunnel healing time is not explained. The matching degree between material degradation and bone tunnel healing cannot be judged.Only the screw was tested, while the matched inserter and tap were not tested; or the fracture and slippage of the tools under ultimate torque were not verified.Only static maximum failure load test was conducted without fatigue test; or the load and frequency settings of the fatigue test lack physiological basis.Raw material quality control is only limited to "compliance with USP/EP standards", lacking specific indicators for specific models (such as specific molecular weight distribution PDI and residual monomer content). The batch stability of the specific product cannot be judged.Only the sterilization validation report is submitted, without providing comparative data of material molecular weight, crystallinity and mechanical properties before and after sterilization. |
To secure smooth technical review approval of interference screw products, manufacturers are advised to complete the following preparations in early project phase:
Full-process sorting: Clarify whether the product is made of metal or polymer, universal or anatomical type, permanent implantation or temporary fixation. Such confirmation defines subsequent test standards and clinical evaluation pathways.
Standard prioritization: Sort out applicable standard systems in advance, including YY/T 0661 Implants for surgery – Semi-crystalline polylactide polymers and copolymer resins, GB/T 13810 Titanium and titanium alloy wrought products for surgical implants, YY/T 1504 Implants for surgery – Test method for axial pullout strength of metallic bone screws, YY/T 1506 Implants for surgery – Test method for driving torque of metallic bone screws, etc., and ensure test protocols comply with latest standard specifications.
Synchronized verification: R&D, testing, registration and quality system construction shall be carried out simultaneously. For polymer-based products in particular, sufficient lead time shall be reserved for long-term degradation study and fatigue testing; these critical tests shall never be postponed to the final stage.
Regulatory consultation: For products with ambiguous classification scope, sophisticated material properties or innovative structures, early consultation applications with CMDE at critical milestones (prior to type testing and clinical evaluation) are recommended to obtain official review guidance.
The core value of interference screws lies far beyond the screw itself, but in the long-term stability of the bone-tendon interface it establishes. Successful registration of interference screws relies not on the simple compilation of complete documents, but on the rigorous and scientific construction of an evidence chain. Review experts expect a professional project team equipped with clinical insight, material expertise and regulatory understanding.
Enterprises shall arrange in-depth participation of professional registration teams at the early stage of the project to fully clarify registration and review requirements. Regulatory requirements shall be taken as the benchmark throughout the whole project process to avoid registration failure caused by negligence of details in the later stage. From the perspective of review experts, applicants are encouraged to strengthen communication and coordination with professional registration teams and regulatory authorities, accurately interpret relevant laws, regulations and guidelines, and prepare registration documents in a scientific and rigorous manner.
Deda Medical specializes in medical device clinical trials, stability and effectiveness evaluation, registration document compilation and quality system docking. It provides full-process customized services including preliminary project judgment, research protocol design, clinical trial assistance and registration document integration.
Cooperating with a professional and experienced registration team to fully integrate material science, biomechanics and clinical needs, and build a complete closed-loop covering material characterization, biomechanical verification, degradation research and clinical evidence, enables enterprises to cope with stringent technical review requirements and ultimately deliver safe and effective treatment solutions for patients in sports medicine.
